<VariationArchive VariationID="56067" VariationName="NM_000170.3(GLDC):c.2267_2269del (p.Phe756del)" VariationType="Deletion" Accession="VCV000056067" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2013-04-04" MostRecentSubmission="2023-06-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="70706" VariationID="56067">
      <GeneList>
        <Gene Symbol="GLDC" FullName="glycine decarboxylase" GeneID="2731" HGNC_ID="HGNC:4313" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6532467" stop="6645729" display_start="6532467" display_stop="6645729" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6532463" stop="6645691" display_start="6532463" display_stop="6645691" Strand="-" />
          </Location>
          <OMIM>238300</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000170.3(GLDC):c.2267_2269del (p.Phe756del)</Name>
      <CanonicalSPDI>NC_000009.12:6554714:AGAAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6554715" stop="6554717" display_start="6554715" display_stop="6554717" variantLength="3" positionVCF="6554714" referenceAlleleVCF="CAGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6554715" stop="6554717" display_start="6554715" display_stop="6554717" variantLength="3" positionVCF="6554714" referenceAlleleVCF="CAGA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F756del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.6554717_6554719del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.6554717_6554719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.6554717_6554719del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.6554717_6554719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016397.1" sequenceAccession="NG_016397" sequenceVersion="1" change="g.95976_95978del">
            <Expression>NG_016397.1:g.95976_95978del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000170.3" sequenceAccession="NM_000170" sequenceVersion="3" change="c.2267_2269del" MANESelect="true">
            <Expression>NM_000170.3:c.2267_2269del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000161.2" sequenceAccession="NP_000161" sequenceVersion="2" change="p.Phe756del">
            <Expression>NP_000161.2:p.Phe756del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_643" sequenceAccession="LRG_643">
            <Expression>LRG_643:g.95976_95978del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000170.2" sequenceAccession="NM_000170" sequenceVersion="2" change="c.2267_2269delTCT">
            <Expression>NM_000170.2:c.2267_2269delTCT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA263350" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="238300.0002" DB="OMIM" />
        <XRef Type="rs" ID="121964975" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000170.3(GLDC):c.2267_2269del (p.Phe756del) AND Non-ketotic hyperglycinemia" Accession="RCV000049476" Version="5">
        <ClassifiedConditionList TraitSetID="3243">
          <ClassifiedCondition DB="MedGen" ID="C0751748">Non-ketotic hyperglycinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000170.3(GLDC):c.2267_2269del (p.Phe756del) AND Glycine encephalopathy 1" Accession="RCV004566899" Version="1">
        <ClassifiedConditionList TraitSetID="93542">
          <ClassifiedCondition DB="MedGen" ID="CN376801">Glycine encephalopathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-07-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2023-06-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1634607</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1996985</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="93542" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="73004" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycine encephalopathy 1</ElementValue>
                <XRef ID="MONDO:0958179" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GCE1</ElementValue>
                <XRef Type="MIM" ID="605899" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301531</ID>
                <ID Source="BookShelf">NBK1357</ID>
              </Citation>
              <XRef ID="CN376801" DB="MedGen" />
              <XRef ID="MONDO:0958179" DB="MONDO" />
              <XRef Type="MIM" ID="605899" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3243" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1933" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycine encephalopathy</ElementValue>
                <XRef ID="MONDO:0011612" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
                <XRef ID="407" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonketotic hyperglycinemia</ElementValue>
                <XRef ID="HP:0008288" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
                <XRef ID="Glycine+Encephalopathy/3115" DB="Genetic Alliance" />
                <XRef ID="237939006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NKH</ElementValue>
                <XRef Type="MIM" ID="605899" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Nonketotic hyperglycinemia (NKH) is the inborn error of glycine metabolism defined by deficient activity of the glycine cleavage enzyme system (GCS), which results in accumulation of large quantities of glycine in all body tissues including the brain. Based on ultimate outcome NKH is categorized into severe NKH (no developmental progress and intractable epilepsy) and attenuated NKH (variable developmental progress and treatable or no epilepsy). The majority of children with NKH have onset in the neonatal period manifest as progressive lethargy evolving into profound coma and marked hypotonia; 85% have severe NKH and 15% attenuated NKH. Those with onset between two weeks and three months typically present with hypotonia; 50% have severe NKH and 50% attenuated NKH. Those with onset after age three months have attenuated NKH. Severe versus attenuated NKH is consistent within families, but the degree of developmental progress in those with attenuated NKH can vary.</Attribute>
                <XRef ID="NBK1357" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7219" />
                <XRef ID="7219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301531</ID>
                <ID Source="BookShelf">NBK1357</ID>
              </Citation>
              <XRef ID="407" DB="Orphanet" />
              <XRef ID="C0751748" DB="MedGen" />
              <XRef ID="MONDO:0011612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS605899" DB="OMIM" />
              <XRef Type="primary" ID="HP:0008288" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32998" SubmissionDate="2010-08-04" DateLastUpdated="2023-06-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="238300.0002_GLYCINE ENCEPHALOPATHY 1" title="GLDC, PHE756DEL_GLYCINE ENCEPHALOPATHY 1" />
        <ClinVarAccession Accession="SCV000032998" DateUpdated="2023-06-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Japanese patient with glycine encephalopathy (GCE1; 605899), Kure et al. (1992) found deletion of phenylalanine-756 in the GLDC gene. Phe756 is located close to lys754, the binding site of pyridoxal phosphate (Kure et al., 1991, 1992). The deletion probably interferes with B6 binding or function.</Attribute>
              <Citation>
                <ID Source="PubMed">1634607</ID>
              </Citation>
              <XRef DB="OMIM" ID="605899" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLDC" />
          </GeneList>
          <Name>GLDC, PHE756DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">PHE756DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="238300.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCINE ENCEPHALOPATHY 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="131270" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS597" />
        <ClinVarAccession Accession="SCV000081910" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">1996985</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000170.2:c.2267_2269delTCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Non-ketotic hyperglycinemia</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="605899" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="131270" TraitType="Disease" MappingType="Name" MappingValue="Non-ketotic hyperglycinemia" MappingRef="Preferred">
        <MedGen CUI="C0751748" Name="Non-ketotic hyperglycinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32998" TraitType="Disease" MappingType="Name" MappingValue="GLYCINE ENCEPHALOPATHY 1" MappingRef="Preferred">
        <MedGen CUI="CN376801" Name="Glycine encephalopathy 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

